Daratumumab in Treating Patients With Multiple Myeloma

Summary

This phase II trial studies the side effects and how well daratumumab works in treating patients with multiple myeloma when the infusion is accelerated. Monoclonal antibodies, such as daratumumab, may interfere with the ability of tumor cells to grow and spread.

Timeline

Start

2017-02-22

Primary completion

2017-07-20

Completion

2017-07-20

Drugs

Indications